Ace investors are renowned individuals who have achieved significant success in the stock market through their investment strategies and portfolios. The decisions and portfolio moves of these ace investors can significantly influence stock prices and market sentiment.
Listed below are some of the stocks in which Ace Investors have made fresh position in Q2FY25.
Jyoti Structures
Jyoti Structures Limited is engaged in the manufacturing of transmission line towers, sub-stations, railway electrification structures, and many more. It also provides EPC services like foundation, erection, and testing of distribution networks, substations, and many more.
With a market capitalization of Rs. 2,750 Crores, the shares of Jyoti Structures Limited closed at Rs. 31.34 per equity share, down 0.10 percent from its previous day’s close price of Rs. 31.37.
Ace Investor Ashish Kacholia has made a fresh position in Jyoti Structures Limited in Q2FY25 by purchasing a 2.5 percent stake consisting of 2.2 Crore equity shares.
Its revenue from operations declined by 52 percent from Rs. 185.17 Crores in Q1FY24 to Rs. 88.29 Crores in Q1FY25, accompanied by profits of Rs. 2.46 Crores to Rs.5.09 Crores.
20 Microns
20 Microns Limited is India’s largest producer of white minerals offering innovative products in the field of Functional fillers, Extenders, and Speciality chemicals. It is principally involved in the trading of calcium carbonate and its white minerals are used in industries like paint and powder coating, plastic, textiles, rubber, paper textiles, and sealants.
With a market capitalization of Rs. 1,097 Crores, the shares of 20 Microns Limited closed at Rs. 310.95 per equity share, up 4.9 percent from its previous day’s close price of Rs. 296.40.
Ace Investor Dolly Khanna has made a fresh position in 20 Microns Limited in Q2FY25 by purchasing a 1.3 percent stake consisting of 4.54Lakh equity shares.
Its revenue from operations grew by 21 percent from Rs. 190.56 Crores in Q1FY24 to Rs. 230.55 Crores in Q1FY25, accompanied by profits of Rs. 14.93 Crores to Rs. 17.9 Crores.
Emkay Global Financial Services
Emkay Global Financial Services Limited is engaged in providing institutional broking, asset management, wealth/ portfolio management, succession planning, investment banking, currency, depository participant, equity broking, commodity broking, distribution of financial products, and investment banking operations.
With a market capitalization of Rs. 6670 Crores, the shares of Emkay Global Financial Services Limited hit a 2 percent upper circuit at Rs. 269 per equity share, from its previous day’s close price of Rs. 264.20.
Ace Investor Dolly Khanna has made a fresh position in Emkay Global Financial Services Limited in Q2FY25 by purchasing a 2.5 percent stake or 6.15 Lakh equity shares.
Its revenue from operations grew by 75 percent from Rs. 46.65 Crores in Q1FY24 to Rs. 81.66 Crores in Q1FY25, accompanied by a loss of Rs. 15 Lakhs to a profit of Rs. 13.95 Crores.
Concord Biotech
Concord Biotech Limited is one of the leading global developers and manufacturers of select fermentation-based APIs across immuno-suppressants and oncology, supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
With a market capitalization of Rs. 20,965 Crores, the shares of Concord Biotech Limited closed at Rs. 2,004 per equity share, down 0.65 percent from its previous day’s close price of Rs. 2,017.05.
Ace Investor Rekha Jhunjhunwala has made a fresh position in Concord Biotech Limited in Q2FY25 by purchasing a 24.1 percent stake or 2.51 Crore equity shares.
Its revenue from operations grew by 10.76 percent from Rs. 194.83 Crores in Q1FY24 to Rs. 215.8 Crores in Q1FY25, accompanied by profits of Rs. 54.49 Crores to Rs. 59.59 Crores.
Written by – Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
